menu
    • menu

    Company profile for Rivus Pharmaceuticals

    NEW Drugs in Dev: 2
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Rivus Pharmaceuticals is dedicated to improving cardio-metabolic health by developing controlled metabolic accelerators (CMAs) that address the underlying metabolic risk factors for cardiovascular mortality and morbidity. Rivus is advancing a new therapeutic approach that harnesses the body’s natural metabolic processes to improve cellular metabolism and reverse the course of disease.Rivus’ controlled metabolic accelerato...
    Rivus Pharmaceuticals is dedicated to improving cardio-metabolic health by developing controlled metabolic accelerators (CMAs) that address the underlying metabolic risk factors for cardiovascular mortality and morbidity. Rivus is advancing a new therapeutic approach that harnesses the body’s natural metabolic processes to improve cellular metabolism and reverse the course of disease.Rivus’ controlled metabolic accelerators (CMAs) are oral, small-molecule therapies designed to effectively address the root cause of metabolic disease, the accumulation of fat and sugars in the body.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Rivus PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    706 B Forest Street, Charlottesville, VA 22903
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.rivuspharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/rivus-pharmaceuticals/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/RivusPharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Rivus Pharma Names Jorge Bartolome AS CEO
    Rivus Pharma Names Jorge Bartolome AS CEO

    25 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/25/3244576/0/en/Rivus-Pharmaceuticals-Appoints-Jorge-Bartolome-as-Chief-Executive-Officer.html

    GLOBENEWSWIRE
    25 Feb 2026
    Share Share
    Rivus Pharma Unveils Phase 2 HU6 Data In MASH at AASLD
    Rivus Pharma Unveils Phase 2 HU6 Data In MASH at AASLD

    07 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/07/3183596/0/en/Rivus-Pharmaceuticals-Announces-New-Data-from-Phase-2-M-ACCEL-Trial-of-HU6-in-MASH-in-Late-Breaker-Oral-Presentation-at-AASLD-The-Liver-Meeting-2025.html

    GLOBENEWSWIRE
    07 Nov 2025
    Share Share
    Rivus's CMA Preclinical Data Showing Fat-Selective Weight Loss
    Rivus's CMA Preclinical Data Showing Fat-Selective Weight Loss

    04 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/04/3180682/0/en/Rivus-Pharmaceuticals-Presents-Preclinical-Data-for-Controlled-Metabolic-Accelerator-CMA-Pipeline-Showing-Fat-Selective-Muscle-Preserving-Weight-Loss-in-Obesity-at-ObesityWeek.html

    GLOBENEWSWIRE
    04 Nov 2025
    Share Share
    Rivus Pharma To Present Ph 2a M-ACCEL Trial Data Of HU6 in MASH
    Rivus Pharma To Present Ph 2a M-ACCEL Trial Data Of HU6 in MASH

    14 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/rivus-pharmaceuticals-to-present-clinical-data-from-phase-2a-m-accel-trial-of-hu6-in-mash-as-late-breaker-oral-presentation-at-aasld-the-liver-meeting-2025-302582497.html

    PR NEWSWIRE
    14 Oct 2025
    Share Share
    Rivus Weight Loss Drug Shows MASH Win, Muscle-Sparing Potential
    Rivus Weight Loss Drug Shows MASH Win, Muscle-Sparing Potential

    25 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/rivus-pharmaceuticals-announces-positive-topline-results-from-phase-2-m-accel-trial-of-hu6-showing-significant-reductions-in-liver-fat-in-patients-with-mash-302488778.html

    PR NEWSWIRE
    25 Jun 2025
    Share Share
    Rivus Ph 2 HU6 Trial Shows Liver Fat Drop in MASH Patients
    Rivus Ph 2 HU6 Trial Shows Liver Fat Drop in MASH Patients

    24 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/rivus-pharmaceuticals-announces-positive-topline-results-from-phase-2-m-accel-trial-of-hu6-showing-significant-reductions-in-liver-fat-in-patients-with-mash-302488778.html

    PR NEWSWIRE
    24 Jun 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search